// App-Quantinova.ai

: A genome-wide screen for inherited genetic variants that affect survival and therapy of resectable pancreatic ductal adenocarcinoma

Researchers

Presenter

  • C. Dimitrakopoulos

Principal Investigators

  • B. Vrugt

  • R. Flury

  • U. Knippschild

  • D. Henne-Bruns

  • R. Graf

  • S. Breitenstein

  • N. Beerenwinkel

  • G. Bond

  • L.F. Grochola

Medical Centers

  • Computational Biology Group, ETH Zurich, Switzerland

  • Institute for Pathology, University Hospital Basel, Basel, Switzerland

  • Institute for Pathology, Cantonal Hospital Winterthur, Switzerland

  • General and Visceral Surgery, University Clinic Ulm, Germany

  • Visceral and Transplant Surgery, University Hospital Zurich, Zurich, Switzerland

  • Surgery, Cantonal Hospital Winterthur, Switzerland

  • Ludwig Institute for Cancer Research, University of Oxford, Oxford, United Kingdom

  • University of Zurich, Switzerland

Locations

  • Switzerland

  • Germany

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreas ductal adenocarcinoma

  • Solid malignancies

  • Microphthalmia, syndromic, 9

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved